Accredo offers a wide range of medications to treat various complex and chronic conditions. Visit Conditions to learn more about treatment, medications, and support for your condition.
| Medication | Condition(s) | Generic/Biosimilar | Manufacturer |
|---|---|---|---|
| Udenyca® (pegfilgrastim-cbqv) |
Myelosuppressive chemotherapy
Hematopoietic subsyndrome
Granulocyte colony-stimulating factor (G-CSF)
|
Biosimilar | Coherus BioSciences, Inc. |
| Ultomiris (ravulizumab-cwvz) |
Paroxysmal nocturnal hemoglobinuria (PNH)
Atypical hemolytic uremic syndrome
Neuromyelitis optica spectrum disorder (NMOSD)
|
Alexion Pharmaceuticals, Inc. | |
| Uplizna® (inebilizumab injection) |
Neuromyelitis optica spectrum disorder (NMOSD)
|
Horizon Therapeutics, plc | |
| Uptravi® (selexipag) | Janssen Pharmaceuticals, Inc. | ||
| Vabysmo® (faricimab-svoa) |
Age-related Macular Degeneration (AMD)
Diabetic macular edema
Retinal vein occlusion
|
Genentech USA, Inc. | |
| Valchlor® (mechlorethamine) |
Lymphoma
|
Helsinn Therapeutics US, Inc. | |
| Vectibix® (panitumumab) |
Gastrointestinal cancer
|
Amgen, Inc. | |
| Velcade® (bortezomib) | Millennium Pharmaceuticals, Inc. | ||
| Veletri® (epoprostenol) | Generic(s) Available | Multiple Manufacturers | |
| Velsipity™ (etrasimod) | Pfizer, Inc. |